Breaking News Instant updates and real-time market news.

AMZN

Amazon.com

$1,620.69

-8.5 (-0.52%)

, HAS

Hasbro

$82.87

-1.16 (-1.38%)

11:53
12/10/18
12/10
11:53
12/10/18
11:53

Amazon rolling out first private label toys for children, TJI says

There appears to be an impending launch of several new AmazonBasics (AMZN) brand private label toys for toddlers and children, according to This Just In, or TJI. The toys are not yet available to ship, but their products pages are now live on Amazon, and TJI would generally anticipate the toys to begin shipping in the coming days or weeks. Publicly traded companies in the toy space include Hasbro (HAS), Mattel (MAT), and JAKKS Pacific (JAKK). Reference Link

AMZN

Amazon.com

$1,620.69

-8.5 (-0.52%)

HAS

Hasbro

$82.87

-1.16 (-1.38%)

MAT

Mattel

$12.94

-0.5 (-3.72%)

JAKK

JAKKS Pacific

$2.18

(0.00%)

  • 03

    Mar

AMZN Amazon.com
$1,620.69

-8.5 (-0.52%)

12/04/18
MSCO
12/04/18
NO CHANGE
MSCO
Market missing risk Amazon poses to UPS, FedEx air volumes, says Morgan Stanley
Morgan Stanley analyst Ravi Shanker said investors so far have been focusing on Amazon's (AMZN) last-mile efforts and build-out of its internal logistics network, but he thinks the market has been missing the potential risk posed to UPS (UPS) and FedEx (FDX) air volumes from the e-commerce giant's in-house Express Air network. While "Amazon Air's" rollout is in the early stages, Shanker already estimates a 200-300 bps impact on the Domestic Air volume growth of UPS and FedEx and expects more erosion. Amazon Air could put 2% of potential revenue for UPS and FedEx at risk in 2018, and Shanker sees that growing to over 10% by 2025, he tells investors. Following the Amazon Air analysis, the analyst lowered his price target for UPS to $87 from $92 and for FedEX shares to $230 from $240. Shanker keeps an Equal Weight rating on FedEx and an Underweight rating on UPS.
12/06/18
RILY
12/06/18
NO CHANGE
Target $300
RILY
Buy
USPS task force report may relieve concerns about Stamps.com, says B. Riley FBR
B. Riley FBR analyst Zach Cummins noted that the task force assigned by President Trump to review the operations of the United States Postal Service finally released its report, which includes a number of proposed administrative and legislative reforms. He believes the report could provide relief for recent investor concerns around Stamps.com's (STMP) viability as a USPS partner and may ultimately provide a longer-term net benefit to the business, Cummins tells investors. While potential price increases could hurt customers such as Amazon (AMZN), FedEx (FDX), and UPS (UPS), Cummins thinks it would represent little-to-no impact to Stamps given that the company does not participate in "last-mile" delivery, he added. Following the release of the report, he reiterated his Buy rating and $300 price target on Stamps.com shares.
12/06/18
JMPS
12/06/18
NO CHANGE
Target $2050
JMPS
Outperform
Amazon lead highlighted in holiday shopping survey, says JMP Securities
Following the firm's recent survey of about 250 online shoppers, JMP Securities analyst Ronald Josey said the results of the polling make him incrementally confident in Amazon's (AMZN) ability to continue to take wallet share. The survey showed Amazon is the first shopping destination of 73% of respondents and it also revealed a Prime member base expansion compared to last year, noted Josey. Walmart (WMT), Target (TGT) and eBay (EBAY) were the other most often used e-commerce sites among respondents, the analyst noted. He keeps an Outperform rating and $2,050 price target on Amazon shares.
12/10/18
WELS
12/10/18
NO CHANGE
WELS
Outperform
Amazon to become number 1 seller of apparel in U.S. this year, says Wells Fargo
Wells Fargo analyst Ike Boruchow notes that traditional retailers continue to perform fairly well, even though e-commerce trends have not moderated and Amazon continues to grow rapidly. It appears that after years of channel conflict, the retail industry broadly is benefiting from simultaneous growth in both "bricks" and "clicks," he adds. The analyst estimates Amazon will become the number 1 seller of apparel in the U.S. in 2018. Citing his survey work, Boruchow says he found that Amazon users are increasingly broadening the categories that they shop for, with a meaningful ramp in year over year responses from customers making purchases in accessories and innerwear. He has an Outperform rating on the shares.
HAS Hasbro
$82.87

-1.16 (-1.38%)

10/16/18
MKMP
10/16/18
NO CHANGE
Target $115
MKMP
Buy
MKM Partners remains bullish on Hasbro in FY19
MKM Partners analyst Eric Handler kept his Buy rating and $115 price target on Hasbro ahead of its earnings on Monday, saying that while some "near term choppiness" on the shares remains probable, he still likes its prospects for FY19. The analyst states that the lingering impact of the Toys R Us bankruptcy, rising freight costs, and international sales pressure from transition to online shopping continue to pose risks, but adds that his 2019-20 catalysts cited in his August upgrade remain intact.
10/23/18
MKMP
10/23/18
NO CHANGE
Target $110
MKMP
Buy
Hasbro price target lowered to $110 from $115 at MKM Partners
MKM Partners analyst Eric Handler lowered his price target on Hasbro to $110 after its "disappointing" Q3 results that saw a miss on revenue, saying he "misjudged" the timing around the impact of Toys R Us liquidation and the comparisons related to last year's campaigns for Moana and Beauty and the Beast. The analyst keeps his Buy rating on expected Hasbro recovery in 2019-2020 however and anticipates the industry headwinds to "lessen going forward". Handler also lists some silver linings from Q3 that included improved orders and online point of sale growth in the high single-digits.
10/23/18
WELS
10/23/18
NO CHANGE
Target $95
WELS
Market Perform
Hasbro price target lowered to $95 from $100 at Wells Fargo
Wells Fargo analyst Timothy Conder lowered his price target for Hasbro to $95 from $100 following Q3 revenue/margin miss on retail transition/clearance, Toys R Us adjustments, and headwinds in key partner brands. The analyst reiterates a Market Perform rating on the shares.
10/23/18
RHCO
10/23/18
NO CHANGE
Target $96
RHCO
Hold
Hasbro price target lowered to $96 from $108 at SunTrust
SunTrust analyst Michael Swartz lowered his price target on Hasbro to $96 after its "disappointing" Q3 results that were highlighted by a 100bps decline in gross margins, revenue pressure from Toys R Us liquidation, and "corrective inventory actions in Europe". The analyst also lowers his FY18 EPS view to $4.30 from $4.92 and his FY19 view to $5.05 from $5.25, anticipating Hasbro's sales and margin pressures to persist until the middle of 2019. Swartz kept his Hold rating on the shares.
MAT Mattel
$12.94

-0.5 (-3.72%)

07/27/18
07/27/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. MATTEL UPGRADED ON TAKEOVER POSSIBILITY: DA Davidson analyst Linda Bolton Weiser upgraded Mattel (MAT) to Neutral from Underperform and raised her price target to $14 from $12. The analyst noted that while the company underperformed in Q2 as she expected, due to the hard 2017 comparisons driven by last year's Cars 3 release and the impact from the Toys R Us liquidation, investor belief that the company could be sold is supporting the stock. Weiser adds that as long as Ynon Kreiz is at the helm, Mattel's elevated valuation could persist. INTEL GETS MULTIPLE DOWNGRADES AFTER EARNINGS: Citi analyst Christopher Danely downgraded Intel (INTC) to Neutral from Buy and lowered his price target for the shares to $50 from $64. The analyst said he sees a "host of margin headwinds coming" and calls the company's rollout of 10 nanometer a "debacle." He believes Intel's valuation multiple will remain under pressure. BofA Merrill Lynch downgraded Intel to Neutral from Buy and lowered its price target to $56 from $62 following the Q2 report. Analyst Vivek Arya said shares will remain range bound given a deceleration in FY19 earnings growth, a competitive position that is becoming tougher with next-gen 10mn product delays, higher capex from insourcing memory, and potential gross margin declines. Intel is down 8.4% in late morning trading. JPMORGAN DEFENDS SYNCHRONY: JPMorgan analyst Richard Shane believes Synchrony Financial (SYF) shares have been "substantially oversold" relative to the fundamental impact to the business from Walmart's (WMT) decision to go with Capital One (COF). The analyst reiterated an Overweight rating on Synchrony and recommended buying the stock at current levels. He estimated a $625M reduction of 2020 net income to common shareholders, or 17c per share in earnings. Shane lowered his price target for Synchrony to $39 from $41 as a result. He believes, however, that the stock will continue to trade at a discount to these levels until there is more clarity about a strategic outcome. AMAZON PRICE TARGET RAISED AT MULTIPLE FIRMS: After reporting its Q2 results, Amazon (AMZN) saw its price target raised by multiple analysts, including by Deutsche Bank analyst Lloyd Walmsley, who raised his price target for Amazon.com to $2,300. He said last night's Q2 results beat his expectations "almost across the board," and added that Amazon remains his top pick among the large cap Internet names. The analyst kept a Buy rating on the shares. Amazon shares are 1.4% higher to about $1,834 in late morning trading.
08/13/18
CEDG
08/13/18
INITIATION
CEDG
Equal Weight
Mattel initiated with an Equal Weight at Consumer Edge
08/13/18
08/13/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Crinetics (CRNX) was initiated with an Outperform at Leerink, an Overweight at Piper Jaffray, and a Neutral at JPMorgan. 2. Hasbro (HAS) was initiated with an Overweight at Consumer Edge while Mattel (MAT) initiated with an Equal Weight. 3. Allakos (ALLK) initiated with an Outperform at William Blair, a Buy at Jefferies, and a Neutral at Goldman Sachs. 4. Constellation Pharmaceuticals (CNST) was initiated with an Overweight at JPMorgan as well as an Outperform at BMO Capital and Oppenheimer. 5. Rubius Therapeutics (RUBY) initiated with an Outperform at Leerink, an Overweight at JPMorgan and Morgan Stanley, as well as a Buy at Jefferies. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
10/26/18
JEFF
10/26/18
NO CHANGE
Target $13
JEFF
Hold
Jefferies says Mattel valuation 'still stretched,' cuts target to $13
At first glance, Mattel's earnings report "was in range," but unpacking the results uncovered a "more challenging set of facts" with sales down 10%, Jefferies analyst Stephanie Wissink tells investors in a post-earnings research note. She lowered her estimates for Mattel and dropped her price target for the shares to $13 from $14. The multiple at current share levels is " still stretched," says Wissink.
JAKK JAKKS Pacific
$2.18

(0.00%)

TODAY'S FREE FLY STORIES

SPCB

SuperCom

$0.66

0.0052 (0.80%)

16:18
11/19/19
11/19
16:18
11/19/19
16:18
Hot Stocks
SuperCom receives Nasdaq listing notice due to late form 20-F »

SuperCom announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AVID

Avid Technology

$7.77

0.18 (2.37%)

16:17
11/19/19
11/19
16:17
11/19/19
16:17
Earnings
Avid Technology sees FY20 adjusted EPS 84c-93c, consensus 73c »

Sees FY20 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Nov

FLNT

Fluent

$1.42

0.11 (8.40%)

16:17
11/19/19
11/19
16:17
11/19/19
16:17
Hot Stocks
Fluent announces $5M shares repurchase program »

Fluent announced that its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AVYA

Avaya

$12.11

-0.22 (-1.78%)

16:17
11/19/19
11/19
16:17
11/19/19
16:17
Hot Stocks
Avaya names Anthony Bartolo as Chief Product Officer »

Avaya Holdings announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

16:17
11/19/19
11/19
16:17
11/19/19
16:17
Technical Analysis
NASDAQ market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WINS

Wins Finance

$10.55

-0.45 (-4.09%)

16:16
11/19/19
11/19
16:16
11/19/19
16:16
Hot Stocks
Wins Finance receives listing qualifications letters from Nasdaq »

Wins Finance Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

16:16
11/19/19
11/19
16:16
11/19/19
16:16
Technical Analysis
NYSE market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SSKN

Strata Skin Sciences

$2.30

-0.3 (-11.54%)

16:15
11/19/19
11/19
16:15
11/19/19
16:15
Hot Stocks
Strata Skin Sciences regains compliance with Nasdaq listing rules »

STRATA Skin Sciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTMX

CytomX Therapeutics

$5.17

-0.01 (-0.19%)

16:15
11/19/19
11/19
16:15
11/19/19
16:15
Initiation
CytomX Therapeutics initiated  »

CytomX Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALNY

Alnylam

$98.02

5.32 (5.74%)

16:14
11/19/19
11/19
16:14
11/19/19
16:14
Initiation
Alnylam initiated  »

Oppenheimer starts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 07

    Dec

  • 04

    Feb

AKCA

Akcea Therapeutics

$19.06

0.31 (1.65%)

, IONS

Ionis Pharmaceuticals

$58.03

0.26 (0.45%)

16:13
11/19/19
11/19
16:13
11/19/19
16:13
Hot Stocks
Akcea Therapeutics announces closing of licensing agreement with Pfizer »

Akcea Therapeutics…

AKCA

Akcea Therapeutics

$19.06

0.31 (1.65%)

IONS

Ionis Pharmaceuticals

$58.03

0.26 (0.45%)

PFE

Pfizer

$37.64

0.43 (1.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 21

    Nov

  • 22

    Nov

  • 07

    Dec

ENDP

Endo

$4.44

-0.02 (-0.45%)

16:11
11/19/19
11/19
16:11
11/19/19
16:11
Hot Stocks
Endo announces FDA accepted for review the original BLA for CCH »

Endo International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNNE

Cannae Holdings

$36.57

-0.27 (-0.73%)

16:10
11/19/19
11/19
16:10
11/19/19
16:10
Hot Stocks
Cannae Holdings names Richard Massey as new CEO »

Cannae Holding announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMRN

Amarin

$22.72

0.09 (0.40%)

16:10
11/19/19
11/19
16:10
11/19/19
16:10
Initiation
Amarin initiated  »

Amarin initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Dec

JNJ

Johnson & Johnson

$134.83

-0.01 (-0.01%)

16:10
11/19/19
11/19
16:10
11/19/19
16:10
Initiation
Johnson & Johnson initiated  »

Johnson & Johnson…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Nov

  • 07

    Dec

  • 21

    Jan

DAN

Dana

$16.81

0.105 (0.63%)

16:09
11/19/19
11/19
16:09
11/19/19
16:09
Initiation
Dana initiated  »

Dana initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

URBN

Urban Outfitters

$28.62

-1.54 (-5.11%)

16:08
11/19/19
11/19
16:08
11/19/19
16:08
Earnings
Urban Outfitters reports Q3 EPS 56c, consensus 57c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 05

    Dec

ALNY

Alnylam

$97.88

5.18 (5.59%)

16:08
11/19/19
11/19
16:08
11/19/19
16:08
Initiation
Alnylam initiated  »

Alnylam initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 07

    Dec

  • 04

    Feb

DFFN

Diffusion Pharmaceuticals

$0.22

-0.0013 (-0.58%)

16:08
11/19/19
11/19
16:08
11/19/19
16:08
Hot Stocks
Diffusion Pharmaceuticals announces increased survival in TSC plus SOC trial »

Diffusion Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NEWM

New Media

$6.33

0.005 (0.08%)

, GCI

Gannett

$9.68

(0.00%)

16:06
11/19/19
11/19
16:06
11/19/19
16:06
Hot Stocks
New Media, Gannett complete merger »

New Media Investment…

NEWM

New Media

$6.33

0.005 (0.08%)

GCI

Gannett

$9.68

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AVYA

Avaya

$12.05

-0.28 (-2.27%)

16:06
11/19/19
11/19
16:06
11/19/19
16:06
Hot Stocks
Avaya names Anthony Bartolo chief product officer »

Avaya Holdings announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

NYMT

New York Mortgage

$6.25

0.01 (0.16%)

16:05
11/19/19
11/19
16:05
11/19/19
16:05
Syndicate
New York Mortgage files to sell 25M shares of common stock »

Morgan Stanley will serve…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IRTC

iRhythm

$71.03

1 (1.43%)

16:05
11/19/19
11/19
16:05
11/19/19
16:05
Hot Stocks
iRhythm receives Nasdaq deficiency notice due to delayed quarterly report »

iRhythm Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSEX

Middlesex Water

$61.64

1.07 (1.77%)

16:04
11/19/19
11/19
16:04
11/19/19
16:04
Syndicate
Middlesex Water files to sell $35M in common stock »

Baird is acting as sole…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORGO

Organogenesis

$8.00

0.01 (0.13%)

16:04
11/19/19
11/19
16:04
11/19/19
16:04
Syndicate
Organogenesis files to sell 9M shares of common stock »

Credit Suisse Securities…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.